Table 1 Patient characteristics and utilization measures by era in which ALL diagnosis occurred
From: Impact of the COVID-19 pandemic on utilization and cost for care of pediatric and young adult ALL
Characteristic | Overall N = 529 | Pre-COVID N = 363 | Overlap COVID N = 63 | COVID era N = 103 | p-value* | |
|---|---|---|---|---|---|---|
Median age, years (Q1, Q3) | 7 (4, 15) | 7 (4, 16) | 8 (4, 17) | 7 (4, 14) | 0.72 | |
Sex, n (%) | Female | 225 (42.5) | 148 (40.8) | 30 (47.6) | 47 (45.6) | 0.46 |
Male | 304 (57.5) | 215 (59.2) | 33 (52.4) | 56 (54.4) | ||
Region, n (%) | Midwest | 149 (28.2) | 100 (27.5) | 18 (28.6) | 31 (30.1) | 0.62 |
Northeast** | ||||||
South | 219 (41.4) | 148 (40.8) | 29 (46) | 42 (40.8) | ||
Unknown** | ||||||
West | 98 (18.5) | 74 (20.4) | 7 (11.1) | 17 (16.5) | ||
Median outpatient encounters (Q1, Q3) | 64 (51, 81) | 64 (51, 82) | 59 (50, 82.5) | 64 (50.5, 76.5) | 0.62 | |
Median inpatient encounters (Q1, Q3) | 5 (3, 7) | 6 (3, 8) | 5 (2.5, 7) | 5 (2, 7) | 0.48 | |
Median inpatient days (Q1, Q3) | 38 (21, 58) | 38 (23, 58) | 37 (19, 59.5) | 41 (18, 56) | 0.84 | |
Median costs, $1000 (Q1, Q3) | 495 (282, 783) | 491 (286, 797) | 501 (298, 690) | 560 (257, 770) | 0.92 | |